OverviewChartNewsTraderScreen

T2 Biosystems/  US89853L3024  /

IEX
2024-05-08  9:59:11 PM Chg. -0.17 Volume Bid- Ask- High Low
3.06USD -5.12% 4,024
Turnover: 12,587.46		 -Bid Size: - -Ask Size: - 3.35 3.04
GlobeNewswire 05-07 T2 Biosystems Announces Letter of Intent to Enter Strategic Partnership for Lyme Disease
GlobeNewswire 05-06 T2 Biosystems Announces First Quarter 2024 Financial Results
GlobeNewswire 05-06 T2 Biosystems Announces Commercial Expansion Through Middle East Distributor
GlobeNewswire 05-06 T2 Biosystems Announces the Conversion of an Additional $15 Million of CRG Term Loan into Equity
GlobeNewswire 04-24 T2 Biosystems to Report First Quarter 2024 Financial Results and Business Updates on May 6, 2024
GlobeNewswire 04-11 T2 Biosystems Shareholders Vote for CRG Debt Conversion into Equity
GlobeNewswire 03-28 T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, I...
GlobeNewswire 03-20 T2 Biosystems Unveils T2Lyme Launch Plans and Provides Additional Business Updates
GlobeNewswire 03-19 T2 Biosystems to Host Investor Call on March 20, 2024 to Unveil its T2Lyme Launch Plans and Provide ...
GlobeNewswire 03-18 T2 Biosystems Announces New Publication Highlighting the Clinical Benefits and Performance of the T2...
GlobeNewswire 03-12 T2 Biosystems Receives Extension to Comply with Nasdaq Listing Requirement
GlobeNewswire 02-15 T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2023 Financial Results
GlobeNewswire 02-15 T2 Biosystems Announces Agreement with CRG for the Conversion of $15 Million of CRG Term Loan into E...
GlobeNewswire 02-15 T2 Biosystems Announces Commercial Expansion Through Distributors in Europe and Asia
GlobeNewswire 02-12 T2 Biosystems Receives FDA 510(k) Clearance for the Expanded T2Bacteria Panel
GlobeNewswire 02-07 T2 Biosystems to Report Fourth Quarter and Full Year 2023 Financial Results and Business Updates on ...
GlobeNewswire 01-18 T2 Biosystems Announces Participation in NIH-funded Antibacterial Resistance Leadership Group (ARLG)...
GlobeNewswire 01-03 T2 Biosystems Announces FDA 510(k) Submission to Expand Use of the FDA-Cleared T2Candida Panel to In...
GlobeNewswire 2023-11-03 T2 Biosystems to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Serv...
GlobeNewswire 2023-11-01 T2 Biosystems Regains Compliance with Nasdaq Listing Requirements
GlobeNewswire 2023-10-24 T2 Biosystems Highlights New Clinical Data Presented at IDWeek 2023 Conference
GlobeNewswire 2023-10-23 T2 Biosystems Announces Amendment and Extension of CRG Term Loan Agreement
GlobeNewswire 2023-10-12 T2 Biosystems Announces Preliminary Third Quarter 2023 Financial Results and Business Updates
GlobeNewswire 2023-10-12 T2 Biosystems Announces FDA 510(k) Submission to Expand the Pathogen Detection on its FDA-Cleared T2...
GlobeNewswire 2023-10-12 T2 Biosystems Announces Reverse Stock Split Effective Today